As filed with the U.S. Securities and Exchange Commission on December 15, 2023 Registration No. 333-274931 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ––––––––––––––––––––––––––––– ESTRELLA IMMUNOPHARMA, INC. (Exact Name of Registrant as Specified in its Charter) _____________________________ | Delaware | 6770 | 86-1314502 | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standard ...

As filed with the U.S. Securities and Exchange Commission on October 10, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 5858 Horton Street, Suite 170 Emeryville, California, 95608 Telephone: (510) 318-9098 (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Executive Offices) ––––––––––––––––––––––––––––– Cheng Liu Chief Executive Officer 5858 Ho ...

As filed with the U.S. Securities and Exchange Commission on October 10, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ––––––––––––––––––––––––––––– ESTRELLA IMMUNOPHARMA, INC. (Exact Name of Registrant as Specified in its Charter) _____________________________ | Delaware | 6770 | 86-1314502 | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standard Industrial | (I.R.S. Empl ...